The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...
Iran's Jamming of Starlink uses military-grade electronic warfare (EW) tools, likely imported from China and Russia deployed ...
BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...
Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have uncovered previously unobserved oscillation ...
Power management is one of the keys for developing successful semiconductors products. There are virtually no applications ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
Nigeria’s satellite broadband market is entering a new competitive phase after NCC granted Amazon’s Project Kuiper a 7-year ...
Practice CBSE Class 12 Physics Top 50 MCQs with Answers based on the latest syllabus and exam pattern. Prepare effectively ...
BHPian BlackBeard recently shared this with other enthusiasts:Hello folks. Since many enthusiasts here are keen on knowing ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback